Main menu


Cell Culture Media Market to Reach $14.64 Billion by 2029 -

READING, Calif., Aug. 1, 2022 (GLOBE NEWSWIRE) — According to a new market research report, Cell culture media market By Product (Serum-Free, Chemically Defined, Classical, Xeno-Free/Animal Component-Free), Application (Monoclonal Antibodies, Diagnostics, Cancer and Stem Cell Research), End User (Pharmaceutical and Biotech, Academic) – By 2029 prediction of“, Published by Meticulus Research®the cell culture media market is expected to grow at a CAGR of 13.2% from 2022 to 2029, reaching $14.64 billion by 2029.

Download a free sample report now @

Cell culture media, also called growth media, are gels or liquids created to support cell growth in artificial environments. When scientists remove cells, organs, or tissues from living organisms, they must be kept in a suitable artificial environment. Cell culture media contain compounds necessary to support and regulate cell growth. These cells are used for biopharmaceutical manufacturing and for research purposes. Growing demand for monoclonal bodies, increasing funding for cell-based research, and rising R&D spending in the life sciences sector are some of the factors driving the cell culture media market.

Impact of the COVID-19 Pandemic: Cell Culture Media Market

During the pandemic, major pharmaceutical and biotech companies worked together to find vaccines and treatments to contain the virus. The idea behind this collaboration was to work together to find solutions as quickly as possible during the pandemic. Collaborations were also made between companies and universities to speed up research and production processes. . Outsourcing of pharmaceutical and biotechnology research to contract research organizations (CROs) has also increased during the pandemic. Below are some examples,

  • In 2022, GSK plc (UK) and Vir Biotechnology, Inc. (US) announced the supply of Sotrovimab to the US for the early treatment of COVID-19. Sotrovimab, a monoclonal antibody, received Emergency Use Authorization (EUA) from the US FDA in May 2021.
  • In May 2020, four CROs, including Charnwood Molecular LTD (UK), Reach Separations (UK), XenoGesis (UK), and Aurelia Bioscience Ltd (UK), launched a shared initiative to continue COVID-19 therapeutic research activities. was built.
  • In April 2020, AstraZeneca plc (UK) and Oxford Biomedica plc (UK) announced an agreement for the global development and commercialization of Oxford’s potential recombinant adenovirus vaccine.
  • In March 2020, Eli Lilly and Company (US) collaborated with AbCellera Biologics Inc. (Canada) on COVID-19 antibody therapy. Both companies leveraged AbCellera’s rapid pandemic response platform to develop and manufacture therapeutic antibodies.
  • In March 2020, Mount Sinai Health System (USA) and Harbor Biomed (Hong Kong) signed a multi-year collaboration to develop antibodies against SARS-CoV-2 using the H2L2 Harbor mouse platform.

Talk to our analysts to understand the impact of COVID-19 on your business.

The global cell culture media market is segmented on the basis of product (serum-free media, chemically defined media, classical media, animal component-free media, and other cell culture media), application. [bioproduction (monoclonal antibody production, therapeutic protein production, vaccine production, and cell & gene therapy)], diagnostics, cancer research, drug screening and development, and stem cell research), end-users (pharmaceutical and biotech companies, academic and research institutions, diagnostic laboratories), and geography. The study also evaluates industry competitors and analyzes regional and national markets.

Based on product, the serum-free media segment is estimated to hold the largest share of the cell culture media market in 2022. A major factor in the large share of this segment is the high usage of cell culture technology in companies and research institutes that require media to grow cells. The main benefits this medium offers include reduced risk of serum-borne pathogens and increased cell culture productivity. Several serum-free media have been developed, generally formulated to support the culture of a single cell type. This segment is also expected to grow at the highest CAGR during the forecast period.

Based on application, the bioproduction segment is expected to grow at the highest CAGR during the forecast period. Increased production of biopharmaceuticals to treat diseases such as cancer, diabetes, rheumatoid arthritis, and other non-communicable diseases will create unprecedented demand for cell culture media, driving the growth of this segment during the forecast period. is expected to promote .

Based on end users, the pharmaceutical and biotech companies segment is expected to grow at the highest CAGR during the forecast period. A key driver is the growing demand for antibody therapeutics and new biosimilars over the next few years.

Quick purchase – Cell Culture Media Market Research Report:

Geographically, North America is estimated to dominate the overall cell culture media market in 2022, followed by Europe and Asia Pacific. Rising demand for cell-based diagnostics and therapies, presence of major players, availability of skilled professionals, and presence of major research institutes are major factors for the large share of the regional market. However, Asia-Pacific is expected to grow at the highest CAGR during the forecast period. This growth has been driven by increased technological progress in biotechnology and pharmaceutical centers, increased focus on vaccine development and clinical research activities, the presence of major research institutes, low manufacturing and labor costs, and the development of medical infrastructure. It is caused.

The report also includes an extensive assessment of the product portfolios, geographic analysis, and key strategic developments adopted by key market players in the industry during the period 2019-2022. In recent years, the cell culture media market has witnessed several new product launches, partnerships, agreements and collaborations, expansions, and acquisitions. For example, in January 2022, Cytiva (US) entered into an agreement with Nucleus Biologics, LLC (US) to develop custom cell media for cell and gene therapy. Also in November 2021, Sartorius AG (Germany) will open a cell culture technology center in Germany.

Major companies operating in this market include Merck KGaA (Germany), Thermo Fisher Scientific Inc. (USA), PromoCell GmbH (Germany), Cytiva (USA), Lonza Group Ltd (Switzerland), Corning Incorporated (USA) , and Becton. , Dickinson and Company (USA), HiMedia Laboratories (India), Sartorius AG (Germany), FUJIFILM Holdings Corporation (Japan), Agilent Technologies, Inc. (USA), Miltenyi Biotec BV & Co. KG (Germany), BIOLOGOS (USA) ) ), STEMCELL Technologies Inc. (Canada), and Cell Applications, Inc. (USA).
Click here to gain more insight into the market with a detailed table of contents and figures.

Report scope:

Cell Culture Media Market by Product

  • serum-free medium
  • chemically defined medium
  • classical media
  • animal component free medium
  • Other cell culture media

Cell Culture Media Market by Application

  • biological production
    • monoclonal antibody production
    • Production of therapeutic proteins
    • vaccine production
    • Cell/gene therapy
  • diagnose
  • cancer research
  • Drug screening and development
  • stem cell research

Cell Culture Media Market by End User

  • Pharmaceutical and biotech companies
  • Academic/research institution
  • diagnostic laboratory

Cell Culture Media Market by Region

  • North America
  • Europe
    • Germany
    • France
    • England
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia Pacific (APAC)
    • China
    • Japan
    • India
    • Rest of Asia Pacific (RoAPAC)
  • latin america
  • Middle East and Africa

Download a free sample report now @

Related reports:

Cell culture market by product [Consumables (Media, Reagents, Sera, Cell Lines), Equipment (Bioreactor, Centrifuge, Cell Counter)]applications (bioproduction, cancer research, stem cells, diagnostics), end users (pharmaceuticals, academia)—global forecasts to 2029

Products & Services, Technologies (Cell Culture, OMICS), Methods (Cell-Based Assays, In Silico), Endpoints (ADME, Genotoxicity, Organ Toxicity, Skin Toxicity), In Vitro Toxicology/Toxicology Testing Market Users by Endpoint, Geography – Global Forecast to 2025

Cell Separation/Cell Separation Market by Product (Reagents, Beads, Media, Disposables, Centrifuges, Filtration Systems), Cell Type (Human, Animal), Technology (Filtration, Surface Markers), Application (Research, Therapeutics) ), End Users – Global Forecast to 2024

About Meticulus Research®

Meticulous Research® was established in 2010 and incorporated in 2013 as a private limited liability company under the Meticulous Market Research Pvt. Companies Act, 1956. Since its inception, the company has become a leading provider of premium market information in North America, Europe, Asia Pacific, Latin America, Middle East and Africa. .

Our name defines our services, strengths and values. Since our inception, we have only succeeded in researching, analyzing and presenting important market data with meticulous attention to detail. With rigorous primary and secondary research techniques, we build powerful capabilities in data collection, interpretation and analysis, including qualitative and quantitative research by our team of top analysts. We design meticulously analyzed, intelligent, value-driven syndicated market research reports, custom research, rapid turnaround research, and consulting solutions to address the business challenges of sustainable growth.

Mr. Kushal Bombe
Meticulus Market Research Inc.
1267 Willis Street, Ste 200 Reading,
California, 96001, USA
United States: +1-646-781-8004
Europe : +44-203-868-8738
Asia Pacific: +91 744-7780008
Visit our website:
Connect with us on LinkedIn-
Content source: